Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Latest Blog Posts

What Is a 510(k) Submission? A Complete 2025 Guide

510k
510k submission

503B Outsourcing Facilities: A Complete 2025 Inspection-Readiness Guide

503A
503B
503B outsourcing

Redica Systems Successfully Completes SOC 2® Audit

No items found.

Biologics Inspection Case Studies Highlight API and Drug Product Deficiencies

API
Case Study
CDER
FDA

Understanding MHRA UK Compliance in Pharma and MedTech

No items found.

FDA Inspection Database: An Essential Tool to Prepare for FDA Inspections

FDA
FDA Database

Company news

view all
Company News

Redica Expands Global Inspection Coverage with New PMDA, Swissmedic, EMA, and MFDS Data

Company News

Redica Systems Announces $30M Series B

Conference Spotlight

view all
Conference Spotlight

FDA: A Pillar of Protection for Patients and Industry

Conference Spotlight

Facility Issues Top Inspection Deficiencies for Biologics

Conference Spotlight

Who is Responsible When GMPs Are Not Followed?

Conference Spotlight

What is a VAI or OAI Regulatory Meeting?

Enforcement

view all
Enforcement

Limiting Plant Access and Sharing Redacted Documents Results in Import Alert and Warning Letter

Enforcement

Granules India FDA 483 Includes Potential Contamination and Data Integrity Findings

Enforcement

Navigating FDA Guidelines for Combination Products: A Comprehensive Guide

Enforcement

ICH Q9 Quality Risk Management in Pharma

Inspection Intelligence

view all
No items found.

Post-market Intelligence

view all
Post-Market Intelligence

FDA PreCheck Initiative Draws Strong Industry Reaction at Recent Stakeholder Meeting

Product News

view all
Product News

Redica and Veeva Training Solutions: What this Partnership Means for GxP Compliance

Regulatory Intelligence

view all
Regulatory Intelligence

Navigating Japan's Regulatory Complexity: What Regulatory Intelligence Teams Need to Know

Regulatory Intelligence

Your Quality Team Is Flying Half the Plane. Here’s What’s Missing.

Regulatory Intelligence

Navigating Russia’s Fragmented Regulatory Landscape

Regulatory Intelligence

GMP Annex 1 Is Effective. Now Watch How Inspectors Are Actually Using It.

Site Intelligence

view all
Site Intelligence

The FDA’s First AI Warning: Over-Reliance Is a cGMP Violation

Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Arijit Saha
Ayan Ghosh
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Sarah Kotler
Scott Sherrill
Tashil Sharma
Yelena Ionova
101
2011 process validation guidance
2022 PDA Annual Meeting
2024 highlights
483
483 Findings
483 observation
483 observations
483 response
483 Response Letter
503A
503B
503B outsourcing
510k
510k submission
adverst event
AI
AI-Powered
ALCOA
ALCOA-C,
Alison Sathe
analytical data
analytical instruments
ANMAT
Anne Johnson
APAC
APAC
API
API Manufacturer
Argentina
artificial Intelligence
aseptic processing
Asia-Pacific
Audit
auditing
audit planning
BIMO
bioburden
Biologics
blame culture
BLAs
Bob McDowall
CAPA
CAPA System
case studies
Case Study
Catalyst
CBER
CDER
CDER Updates
CDMO
Cell and Gene
CFR
CGMP
CGT
change control
change management
China
citations
cleaning
cleaning validation
cleanroom
clinical hold
clinical investigator
clinical research organization
Clinical Trial Guidance
clinical trial monitor
clinical trials
clinical trial sponsor
CMC
CMO
Code of Federal Regulations
COFEPRIS
Colombia
Combination Products
Combination Products
Comparison report
Compliance
compliance officer
ConOps
consent decree
Contamination
contamination control
Context Engineering
Contract Facilities
contract manufacturing
contract manufacturing organization
contract operations
Cost of Quality
CPAP Machines
CPO
CROs
cross-contamination
CVM
DaaS
data
Data-as-a-service
data culture
Data Enrichment
Data Explorer